Attached files
| file | filename |
|---|---|
| 8-K - WaferGen Bio-systems, Inc. | v173379_8k.htm |
Exhibit
99.1
|
February
4, 2010
FOR
IMMEDIATE
RELEASE
|
|
Contact:
WaferGen
Mona
Chadha
510-651-4450
Mona.Chadha@WaferGen.com
|
WAFERGEN
TO PRESENT AT THE BIO CEO AND INVESTOR CONFERENCE; PRESENTATION TO BE
WEBCAST
Fremont, Calif., February 4, 2010
- WaferGen Biosystems, Inc. (OTCBB:WGBS), a leading developer of
state-of-the-art genetic analysis systems, today announced that Alnoor Shivji,
Chairman and CEO, will deliver a corporate presentation at the 12th annual BIO
CEO and Investor Conference in New York at The Waldorf-Astoria Hotel on Monday,
February 8, 2010, at 8:30 a.m. Eastern Time. Mr. Shivji’s presentation will
cover the company’s progress toward positioning the WaferGen SmartChip™
Real-Time PCR System as the platform of choice for biomarker discovery and
validation.
The
presentation will be Webcast live and may be accessed at www.wafergen.com. It
will be available for 90 days.
WaferGen
Biosystems, Inc. is an emerging leader in the development, manufacture and sale
of state-of-the-art systems for genetic analysis for the life science and
pharmaceutical industries. The company recently launched its new innovative
fee-based service for gene-expression profiling while continuing to actively
develop its SmartChip Real-Time PCR System that is designed as the first whole
genome, high-throughput gene expression real-time PCR platform. Based on
collaborations established with leading research institutions, WaferGen believes
that the SmartChip Real-Time PCR System is positioned as the platform of choice
for biomarker discovery and validation. For additional information, please see
http://www.wafergen.com.
Forward
Looking Statements
This
press release contains certain "forward-looking statements". Such statements
include statements relating to the company’s beliefs relating to the positioning
of the company’s SmartChip technology as the platform of choice for biomarker
discovery and validation. Such statements are not historical facts and may be
preceded by the words "intends," "may," "will," "plans," "expects,"
"anticipates," "projects," "predicts," "estimates," "aims," "believes," "hopes,"
"potential" or similar words.
Forward-looking
statements are not guarantees of future performance, are based on certain
assumptions and are subject to various known and unknown risks and
uncertainties, many of which are beyond the control of the company. Actual
results may differ materially from the expectations contained in the
forward-looking statements. Factors that may cause such differences include the
risks that: (i) the company may be unsuccessful in commercially developing its
products or in achieving market acceptance of new and relatively unproven
technologies; (ii) the company will need to raise additional capital to meet its
business requirements in the future and the company may not be able to do so on
reasonable terms or at all; (iii) the company’s proprietary intellectual
property rights may not adequately protect its products and technologies; and
(iv) the company expects intense competition in its target markets, including
from companies that have much greater resources than the company, and there can
be no assurance that the company will be able to compete effectively. More
detailed information about the company and the risk factors that may affect the
realization of forward-looking statements is set forth in the company’s filings
with the Securities and Exchange Commission, including the company’s Annual
Report on Form 10-K for the year ended December 31, 2008 and the company’s
Quarterly Report on Form 10-Q for the quarter ended September 30, 2009.
Investors and security holders are urged to read this document free of charge on
the SEC’s web site at www.sec.gov. The company does not undertake to publicly
update or revise its forward-looking statements as a result of new information,
future events or otherwise.
# #
#